Used primarily as a pharmaceutical intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system active compounds. Its fluorinated aromatic structure and amine functionality make it valuable in developing bioactive molecules with enhanced metabolic stability and receptor selectivity. Commonly employed in research and development of antidepressants and anxiolytic agents. Suitable for use in medicinal chemistry for structure-activity relationship (SAR) studies involving phenylpropanamine derivatives.